D. Boral Arc Acquisition I Corp. is a blank check company, which engages in the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in New York City, New York. The company went IPO on 2025-07-31. The firm is incorporated for the purpose of effecting a merger, stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The firm has not selected any specific Business Combination target, and the Company has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The firm has no operations and has generated no revenues.
最新の財務諸表(Form-10K)によると、D Boral ARC Acquisition I Corpの総資産は$0で、純亏损は$0です。
BCARUの主要な財務比率は何ですか?
D Boral ARC Acquisition I Corpの流動比率は0、純利益率は0、1株当たり売上高は$0です。
D Boral ARC Acquisition I Corpの収益はセグメントまたは地域別にどのように分けられていますか?
D Boral ARC Acquisition I Corp 最大收入来源是 Novel Antibody-based Cancer Medicines,在最近的收益报告中收入为 7,670,902。就地区而言, China 是 D Boral ARC Acquisition I Corp 的主要市场,收入为 7,670,902。
D Boral ARC Acquisition I Corpは収益を上げていますか?
否、最新の財務諸表によると、D Boral ARC Acquisition I Corpの純亏损は$0です。